Our results demonstrate for the first time that Wortmannin, a prototype and classical PI3K inhibitor, suppresses PI3K/AKT pathway and prevents the formation and progression of experimental abdominal aortic aneurysm in rats. This evidence concerns the gene AKT1 and abdominal aortic aneurysm.